SavedAdd your journal

Journals / Eastern Journal of Medicine / 2022 / Cilt: 27 - Sayı: 1

P Wave Dispersion in COVID-19

Mustafa TUNCER
Fatih ÖZTÜRK
Rabia ÇOLDUR
Medeni KARADUMAN
Yılmaz GÜNEŞ
Pages
91–94
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Increased Pd was observed as an indication that COVID-19 affects the atriums.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The effects of COVID-19 on the heart are still not fully known.
📊
Key Findings & Data:In this study, we investigated how COVID-19 affects the P interval.
💡
Conclusion & Impact:Increased Pd was observed as an indication that COVID-19 affects the atriums.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The effects of COVID-19 on the heart are still not fully known. In this study, we investigated how COVID-19 affects the P interval. Electrocardiographies (ECG) of 30 COVID-19 patients and the control group consisting of 23 healthy volunteers were examined and dispersion (Pd) of the P wave was calculated. Compared to control group mean Pd (40,1±6,6 vs. 49,6±11,5, p=0,006) values were significantly higher in Covid19 patients. Increased Pd was observed as an indication that COVID-19 affects the atriums.

🔖

Cite This Article

TUNCER, M., ÖZTÜRK, F., ÇOLDUR, R., KARADUMAN, M., GÜNEŞ, Y. (2022). P Wave Dispersion in COVID-19. Eastern Journal of Medicine, Cilt: 27 - Sayı: 1, 91–94. https://ajindex.com/articles/493403

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Kapoor A, Pandurangi U, Arora V, Gupta A, Jaswal A, Nabar A, et al. Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society. Indian Pacing Electrophysiol J. 2020
  2. Inciardi RM, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA cardiology. 2020
  3. Guo T, Fan Y, Chen M. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;27
  4. Mercuro NJ, Yen CF, Shim DJ, Maher TR, McCoy CM, Zimetbaum PJ, et al. Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19). JAMA cardiology. 2020
  5. Bessiere F, Roccia H, Deliniere A, Charriere R, Chevalier P, Argaud L, et al. Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit. JAMA cardiology. 2020
  6. Members ATF, Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, et al. 2012 focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation developed with the special contribution of the European Heart Rhythm Association. European heart journal. 2012;33(21):2719-47
  7. Dilaveris PE, Gialafos JE. P wave dispersion: A novel predictor of paroxysmal atrial fibrillation. Annals of Noninvasive Electrocardiology. 2001;6(2):159-65
  8. Perzanowski C, Ho AT, Jacobson AK. Increased P-wave dispersion predicts recurrent atrial fibrillation after cardioversion. Journal of electrocardiology. 2005;38(1):43-6
  9. Gurok MG, Korkmaz H, Yıldız S, Bakış D, Atmaca M. QT and P-wave dispersion during the manic phase of bipolar disorder. Neuropsychiatric disease and treatment. 2019;15:1805
  10. Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen T, Pierard LA, et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. European Heart Journal–Cardiovascular Imaging. 2013;14(7):611-44
  11. Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic dis